Prospect of a ban of TV advertising in the US for drugs is a negative.

Marginally Below Consensus, Improved Debt Position, and Positive Outlook for FY25 Dividend.

H1 results better than expected

Beat in Q3 - €1.5bn SBB announced

Mixed Q4 results - Guidance trimmed

Strong in line Q3 profit. Leverage is down. Buy Reiterated